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Summary  The  Dominican  Republic  (DR)  is  the  second  largest  Caribbean  nation
and,  with  Haiti,  the  DR  accounts  for  nearly  three-quarters  of  the  cases  of  human
immunodeﬁciency  virus  (HIV)  infection  in  the  Caribbean  region  and  the  highest  rates
of  TB  in  the  Americas.  The  present  study  estimated  the  burden  of  serious  fungal
infections  and  some  other  mycoses  in  the  DR.  The  data  were  extracted  from  the
World  Health  Organization  Stop  Tuberculosis  (WHO  STOP  TB)  program,  the  Joint
United  Nations  Program  on  HIV/AIDS  (UNAIDS),  and  searches  for  relevant  literature
via  MEDLINE,  PubMed,  MedFacts,  and  so  on.  The  chronic  pulmonary  aspergillosis
(CPA),  allergic  bronchopulmonary  aspergillosis  (ABPA),  and  severe  asthma  with  fun-
gal  sensitization  (SAFS)  rates  were  derived  from  the  asthma  and  TB  rates.  When
no  data  regarding  mycoses  were  available,  we  used  speciﬁc  populations  at  risk
and  the  frequencies  of  fungal  infection  in  each  of  these  populations  to  estimate
the  national  prevalence.  Among  its  population  of  10,090,000,  we  estimated  that
221,027  (2.2%)  have  a  serious  fungal  infection,  including  158,134  women  with  recur-
rent  vulvovaginal  candidiasis.  We  estimated  high  numbers  of  25,150  for  ABPA  and
34,000  for  severe  asthma  fungal  sensitization  (SAFS)  (250  and  529/100,000,  respec-
tively).  CPA  was  common,  with  an  estimated  2122  cases,  of  which  707  followed
pulmonary  TB.  The  annual  prevalence  of  CPA  was  estimated  to  be  1374  cases.
Four  cases  of  histoplasmosis  and  several  cases  of  chromoblastomycosis  have  also
been  reported.  Pityriasis  versicolor  and  tinea  capitis  are  frequent  in  children,  and
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Introduction
The  Dominican  Republic  is  the  second  largest
Caribbean nation  (after  Cuba),  both  in  area
and population,  with  48,445  square  kilometers
(18,705 sq  miles)  and  an  estimated  10  million  peo-
ple, of  which  one  million  live  in  the  capital  city  of
Santo Domingo.  With  the  exception  of  sub-Saharan
Africa, the  Caribbean  region  has  the  highest  HIV
prevalence  in  the  world.  The  Dominican  Republic
(DR) and  Haiti  account  for  nearly  three-quarters  of
the HIV  cases  in  this  area  and  also  exhibit  the  high-
est rates  of  TB  in  the  Americas  according  to  the
World Health  Organization  [1]. Some  researchers
have estimated  that  between  6  and  11  percent  of
those with  TB  in  the  DR  are  also  infected  with  HIV
[1],  which  presents  a  dual  challenge.  La  Romana  is
the third  largest  city  in  the  DR  and  is  located  in
one of  the  regions  that  is  most  seriously  affected
with HIV  due  to  the  high  number  of  disenfranchised
Haitians. The  incidence  of  chronic  obstructive  pul-
monary disease  (COPD)  in  the  DR  is  0.5  per  1000  of
the population  [2].
Data  regarding  the  occurrence  of  fungal  infec-
tions in  the  Caribbean  Region  are  scarce.  However,
there have  been  several  reports  of  occurrences
of mycoses  in  Cuba.  Outbreaks  of  histoplasmo-
opportunistic  mycoses,  a  high  prevalence  of  vul-
vovaginal candidiasis  in  pregnant  women  (42.3%)
has been  recorded  [7], and  a  very  recent  review
documented 97  cases  of  cryptococcosis,  82  of
which  occurred  in  AIDS  patients  and  15  in  non-
AIDS patients  [8]. Moreover,  Pneumocystis  jirovecii
pneumonia  (PCP)  is  known  to  occur  frequently  in
AIDS patients  [9]. An  autopsy  study  of  307  AIDS
patients revealed  invasive  pulmonary  aspergillosis
incidence of  2.2%  [10], and  a case  of  pulmonary
aspergilloma has  also  been  reported  [11]. Super-
ﬁcial mycoses,  viz.  dermatophytic  infections  and
mycotic keratitis,  have  also  been  recognized  to  be
frequent in  Cuba  [5].  The  limited  information  that
is available  regarding  the  prevalence  of  mycoses  in
Jamaica and  Trinidad  and  Tobago  has  been  reviewed
in recent  reports  [12,13]. There  have  only  been  iso-
lated case  reports  of  deep  mycoses  and  other  fungal
infections  in  most  other  parts  of  the  Caribbean,  for
example,  Haiti  and  Barbados.
Considering  the  large  size  of  the  population  and
the high  prevalence  of  HIV  and  TB  in  the  DR,
serious fungal  infections,  including  opportunistic
mycoses, should  be  common  despite  the  scarcity
of reports  of  such  infections  in  this  country.  The
systemic  fungal  infections  that  have  been  recorded
in the  DR  include  two  cases  of  AIDS-associatedsis have  been  described  in  French  and  German
bat researchers  returning  from  explorations  of  bat
caves in  Cuba  [3,4].  Numerous  cases  of  chromoblas-
tomycosis and  several  cases  of  sporotrichosis  and
mycetoma  have  been  reported  [5,6].  Regarding
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iological  investigations  are  urgently  required  to  validate
 serious  fungal  infections  in  the  DR.
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istoplasmosis  [14,15]  and  a case  of  Aspergillus
eningitis that  was  successfully  treated  with  itra-
onazole [16].  Some  superﬁcial  mycoses,  such  as
ityriasis versicolor  and  tinea  capitis,  which  are
aused by  Microsporum  audouinii  and  Trichophyton
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4stimates  of  serious  fungal  infections  in  the  Domini
onsurans, have  been  reported  to  be  common  in
hildren  [17—19]. A  case  of  eumycetoma  has  also
een reported  [20].  The  present  study  attempted
o estimate  the  burden  of  serious  fungal  infections
n the  DR.
aterials and methods
here  are  currently  no  epidemiology  papers  that
ave reported  on  the  fungal  infection  rates  in  the
R, so  every  estimate  is  based  on  modeling.  A  sim-
le deterministic  model  that  was  created  in  Excel
nd has  consistently  been  applied  in  many  countries
y the  LIFE  program  (www.LIFE-worldwide.org) was
sed here  [12,21]. We  extracted  data  from  the
HO STOP  TB  program  [22]  and  UNAIDS  [23]  and
lso searched  for  relevant  literature  via  MEDLINE,
ubMed, MedFacts,  and  several  search  engines
sing different  sets  of  key  words.  Where  no  data
xisted, we  used  the  speciﬁc  at-risk  populations
nd the  fungal  infection  frequencies  in  those
opulations to  estimate  the  national  incidence  or
revalence  depending  on  the  condition.  The  search
or data  extended  over  several  months  from  2013
o 2014.  The  ABPA  and  severe  asthma  with  fun-
al sensitization  (SAFS)  estimates  were  based  on  a
.97% adult  clinical  asthma  rate  [24,25],  and  CPA
as based  on  the  TB  rates  [26]. Other  assump-
ions were  based  on  the  incidences  reported  in  the
ocal and  international  literature.  The  denominator
ncluded the  overall  DR  population  and  the  numbers
f patients  with  HIV/AIDS  and  respiratory  diseases.
esults
he  DR  population  was  estimated  to  be  10,090,000
illion people  in  2011  [26];  children  (0—14  years)
omprise 31%  of  the  population,  and  9%  are  >60
ears old.  An  estimated  158,134  women  experi-
nce >4  attacks  of  vaginal  candidiasis  annually  (6%
omen 15—50  years)  [27].  The  burden  of  HIV/AIDS
n 2012  was  estimated  to  be  45,000  patients  or  0.7%
f adults;  27,000  of  these  patients  have  CD4  counts
350/uL,  and  21,138  (78%)  have  been  treated  with
ntiretroviral  therapy  (ARVs)  [28]. Moreover,  there
ere an  estimated  1700  AIDS  deaths  in  2013  [29].
ssuming that  50%  of  the  untreated  patients  have
D4 cell  counts  <200/uL,  then  90%  (1319  patients)
f the  patients  probably  develop  oral  candidiasis
30].  Regarding  esophageal  candidiasis,  an  estimate
f 1183  cases  has  been  reported  annually  based  on
he assumptions  that  20%  of  the  HIV  patients  who
re not  on  ARVs  [28]  and  5%  of  those  who  are  on
c
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RVs  [28]  are  infected.  Assuming  that  50%  of  those
atients  who  are  not  on  ARVs  and  have  CD4  counts
200/uL progress  to  life-threatening  opportunis-
ic infections  each  year,  the  rate  of pneumocystis
neumonia  (PCP)  is  80%  [29,30]  and  the  rate  of  cryp-
ococcal  meningitis  (CM)  is  10%  [30];  thus,  234  PCP
ases and  29  CM  cases  are  anticipated  annually  in
he DR  population.
The adult  asthma  population  has  been  esti-
ated at  an  extraordinary  1  million  people  based
n a  9.97%  clinical  asthma  rate  [24].  Using  an
BPA rate  of  2.5%  based  on  other  studies  [25],
he DR  is  estimated  to  have  25,150  adult  ABPA
atients (250/100,000).  Assuming  that  33%  of  the
ost severe  adult  asthmatics  are  sensitized  to
ungi, ∼34,000  patients  with  SAFS  are  anticipated
529/100,000).  Further,  3896  cases  of  pulmonary  TB
ere reported  in  2011,  which  resulted  in  an  esti-
ate of  224  new  CPA  cases  annually  and  a 5-year
revalence of  707  affected  people  [31]  assuming  an
nnual death  rate  of  15%.  If  TB  accounts  for  33%  of
he cases  [31], then  the  total  CPA  prevalence  is  2122
ases in  the  DR  (80/100,000).  Invasive  aspergillo-
is (IA)  in  patients  with  hematological  malignancy
s estimated  to  affect  61  patients  assuming  a  10%
ttack rate  in  acute  myeloblastic  leukemia  (AML)
atients  [32]  and  an  equivalent  number  in  non-
ML hematological  patients  [33,34]. Additionally,
he COPD  rate  is  estimated  to  be  13.4%  in  those
ver 40  years  old  or  a  total  of  374,262  patients.
ssuming a hospital  admission  rate  identical  to  that
f Trinidad  and  Tobago  (13%)  and  a 1.3%  rate  of
nvasive aspergillosis  in  these  patients  [35], the
stimated  IA  rate  is  316  patients  annually,  with
OPD as  the  underlying  risk  factor,  and  all  of  these
atients  are  probably  treated  with  corticosteroids
35]. There  is  a report  of  a  case  of  Aspergillus
eningitis  that  was  successfully  treated  with  itra-
onazole  [16], but  no  such  reports  exist  for  invasive
spergillosis  in  immunocompromised  patients.  If
he incidence  of  candidemia  is  5/100,000  (a low
nternational  average),  505  cases  of  candidemia
nd 76  cases  of  post-surgical  Candida  peritonitis
ccur annually  [36,37].
Regarding  superﬁcial  mycoses  in  the  DR,  pityr-
asis versicolor  and  tinea  capitis  are  known  to
e common  in  children  [17]. In  a study  of  tinea
apitis in  84  boys  and  34  girls,  the  predominant
tiological agents  were  found  to  be  T. tonsurans
61.16%), M.  audouinii  (24.27%),  and  Microsporum
anis (11.65%)  [18].  In  a  previous  study,  11%  of
81 individuals  with  scalp  infections  caused  by  M.
anis had  an  inﬂammatory  form  of  tinea  capitis
kerion), and  these  forms  were  subdivided  into
uppurative  folliculitis  (11%),  suppurative  folliculi-
is with  suppurative  dermatitis  (37%),  suppurative
10  H.C.  Gugnani,  D.W.  Denning
Table  1  Estimated  burden  of  fungal  disease  in  Dominion  Republic.
Fungal  disease  Underlying  disease  Total  n/100k
None  HIV/AIDS  Respiratory  Cancer/Tx  ICU
Oesophageal  candidiasis ?  1183  —  ? —  3805  36.7
Candidaemia  —  —  —  353  151  136  5
Candida  peritonitis  —  —  —  —  76  76  0.75
RVVC  (4×/year+)  158,134  —  —  —  —  158,134  3134
ABPA  —  —  25,149  —  —  25,149  249
SAFS  —  —  33,197  33,197  329
CPA  —  —  1459  —  —  1374  55
IA  —  —  —  61  ?  ?  0.8
Mucormycosis  —  —  —  20  —  ?  0.2
CM  ?  29  —  ? —  29  0.29
PCP  —  234  ? ? —  234  2.32
Histoplasmosis  ?  ?  ? —  —  ?  ?
Fungal  keratitis  ?  —  —  —  —  —  ?
Tinea  capitis  ?  —  —  —  —  ?  ?
Total  burden  estimated 158,134+  5101+  59,720  434+  227+  2,293,681+
ABPA, allergic bronchopulmonary aspergillosis; CM, cryptococcal meningitis; PCP, Pneumocystis jirovecii pneumonia; IA, invasive
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iaspergillosis; CPA, chronic pulmonary aspergillosis; RVVC, rec
sensitization; ?, many cases likely in this category, but the num
folliculitis  with  suppurative  and  granulomatous  der-
matitis (SGD,  26%)  and  SGD  with  ﬁbrosing  dermatitis
(26%) [19].  Regarding  the  subcutaneous  mycoses,
a case  of  mycetoma  caused  by  Maduralla  myce-
tomatis in  the  foot  of  a  42-yr-old  ﬁsherman  [20]
and  a  case  of  mycetoma  in  the  scalp  caused  by
M. canis  [19]  have  been  reported.  Several  cases  of
chromoblastomycosis  are  also  known  [38].
Two cases  of  AIDS-associated  disseminated  histo-
plasmosis  in  Dominican  immigrants  have  been
detected in  the  USA  [14,15]. In  another  two
cases of  histoplasmosis  in  immunocompetent  Ital-
ian patients,  the  infections  were  acquired  in  the
DR [39].  However,  it  was  not  possible  to  estimate
the burden  of  histoplasmosis  in  the  DR  because  no
data from  this  country  exist.  We  were  also  unable
to estimate  the  number  of  cases  of  fungal  keratitis,
and some  estimates  are  incomplete,  notably,  those
for invasive  aspergillosis,  because  the  relevant  data
are not  available  (Table  1).
Discussion
HIV/AIDS  is  a  major  public  health  problem  in  the
Caribbean  and  the  northern  tip  of  South  America.
In the  DR,  there  are  approximately  62,000  patients
with HIV/AIDS,  and  24,000  of  these  patients  have
CD4 counts  <350/uL  and  are  not  being  treated
[40,41].  Based  on  these  data,  it  appears  that  seri-
ous fungal  infections  and  opportunistic  mycoses  are
much more  frequent  than  presently  observed.  An
extensive  search  of  the  literature  did  not  reveal
t
o
p
at vulvovaginal candidiasis; SAFS, severe asthma with fungal
is not known and is inestimable with current knowledge.
ny  data  regarding  the  histoplasmin  sensitivity
f the  human  population  of  the  DR.  However,  a
eport of  two  AIDS-associated  cases  of  histoplas-
osis in  Dominican  patients  [14,15]  and  another
eport of  two  cases  of  the  disease  in  immunocom-
etent Italian  patients  who  developed  after  visiting
he DR  [39]  provide  evidence  of  the  endemicity
f histoplasmosis  in  this  country.  With  increased
wareness and  diagnostic  acumen,  several  cases  of
he disease  in  immunocompromised  and  immuno-
ompetent patients  are  likely  to  be  detected  in
he DR.  Cave-associated  histoplasmosis  has  been
eported  in  Cuba  [3,4], Jamaica  [12], and  Trinidad
nd Tobago  [13]. There  are  several  caves  in  the  DR
42]. The  inside  atmosphere  in  one  of  these  caves
s warm  and  humid,  and  these  caves  harbor  sev-
ral species  of  bats;  thus,  it  would  be  worthwhile
o investigate  the  presence  of  Histoplasma  capsu-
atum in  these  bats  and  the  old  bat  guano  admixed
ith the  soil  in  this  cave.  Skin  testing  of  human
opulation around  and  visitors  to  this  cave  might
elp to  assess  the  asymptomatic  Histoplasma  infec-
ion status.  Creating  awareness  of  the  possibility  of
linical histoplasmosis  among  physicians  and  public
ealth authorities  in  this  country  might  lead  to  the
etection of  several  cases  of  the  disease.  Reports  of
 single  case  of  eumycetoma  [20]  and  several  cases
f chromoblastomycosis  [38]  indicate  the  endemic-
ties of  these  mycoses  in  the  DR,  and  it  is likely
hat many  more  undetected  cases  of  these  diseases
ccur  in  this  country.  Several  cases  of  equine  lym-
hangitic  sporotrichosis  were  recorded  in  the  DR
s early  as  1942  based  on  clinical  features  [43].  It
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[stimates  of  serious  fungal  infections  in  the  Domini
an  be  assumed  that  human  sporotrichosis  possi-
ly exists  in  the  DR,  although  no  cases  have  been
eported.
onclusion
n  the  Dominion  Republic  (DR),  there  are  approxi-
ately 62,000  patients  with  HIV/AIDS,  and  24,000
f these  have  CD4  counts  <350/uL  and  are  not  being
reated.  These  cases  account  for  75%  of  the  total
IV-infected population  in  the  Caribbean  [1]. More-
ver, the  DR  has  the  highest  incidence  of  TB  in  the
mericas,  and  according  to  the  WHO,  between  6
nd 11  percent  of  those  with  TB  in  the  DR  are  co-
nfected  with  HIV  [1]. The  incidence  of  COPD  is  0.5
er 1000  of  the  population  [2]. In  view  of  the  afore-
entioned facts,  the  incidence  of  fungal  infections
n this  country  is  almost  certainly  much  higher  than
reviously  known.  We  have  estimated  that  over
20,000  people  in  the  DR  probably  suffer  from  seri-
us fungal  infections  each  year,  and  most  of  these
ases are  related  to  asthma,  prior  TB,  recurrent
ulvovaginal  candidiasis  (RVVC),  and  HIV  infection.
ocal  epidemiological  studies,  preferably  in  col-
aboration  with  international  experts  on  mycotic
nfections, are  urgently  required  to  establish  the
alidity  of  these  estimates.
unding
o  funding  sources.
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